Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Tomoaki Kimoto is active.

Publication


Featured researches published by Tomoaki Kimoto.


Journal of Pharmaceutical Sciences | 2014

Protein–Poly(amino acid) Complex Precipitation for High-Concentration Protein Formulation

Takaaki Kurinomaru; Takuya Maruyama; Shunsuke Izaki; Kenji Handa; Tomoaki Kimoto; Kentaro Shiraki

A method for concentration of protein solutions is required for high-dosage protein formulation. Here, we present a precipitation-redissolution method by poly(amino acid) for proteins, including therapeutic enzymes, antibodies, and hormones. The proteins were fully precipitated by the addition of poly-L-lysine or poly-L-glutamic acid at low ionic strength, after which precipitate was dissolved at physiological ionic strength. The activities and secondary structures of redissolved proteins, especially antibodies, were almost identical to the native state. The precipitation-redissolution method is a simple and rapid technique for concentration of protein formulations.


Journal of Pharmaceutical Sciences | 2017

Stabilizing Effects for Antibody Formulations and Safety Profiles of Cyclodextrin Polypseudorotaxane Hydrogels

Taishi Higashi; Naoko Ohshita; Tatsunori Hirotsu; Yoshihito Yamashita; Keiichi Motoyama; Sawako Koyama; Ruriko Iibuchi; Takayuki Uchida; Shiuhei Mieda; Kenji Handa; Tomoaki Kimoto; Hidetoshi Arima

Antibodies often have poor physicochemical stability during storage and transport, which is a serious drawback for the development of antibody-based drugs. In this study, we prepared polypseudorotaxane (PPRX) hydrogels consisting of cyclodextrins (CyDs) and polyethylene glycol, and evaluated them as stabilizers for commercially available antibody-based drugs. α-CyD and γ-CyD formed PPRX hydrogels with polyethylene glycol (molecular weight 20,000 Da) in the presence of antibody-based drugs such as omalizumab, palivizumab, panitumumab, and ranibizumab. Importantly, both α- and γ-CyD PPRX hydrogel formulations provided high stabilizing effects (ca. 100%) to the all antibody-based drugs used in this study. Furthermore, approximately 100% of the binding activity of omalizumab to the immunoglobulin E receptor was retained after the release from the hydrogels. Plasma levels of omalizumab after subcutaneous injection of the γ-CyD PPRX hydrogel to rats were equivalent to those of omalizumab alone. According to the results of blood chemistry tests, the weights of organs and histological observations α- and γ-CyD PPRX hydrogels induced no serious adverse effects. These results suggest that CyD PPRX hydrogels are useful as safe and promising stabilizing formulations for antibody-based drugs.


Journal of Pharmaceutical Sciences | 2015

Stress Tolerance of Antibody-Poly(Amino Acid) Complexes for Improving the Stability of High Concentration Antibody Formulations.

Shunsuke Izaki; Takaaki Kurinomaru; Kenji Handa; Tomoaki Kimoto; Kentaro Shiraki

The stabilization of antibodies in aqueous solution against physical stress remains a problematic issue for pharmaceutical applications. Recently, protein-polyelectrolyte complex (PPC) formation using poly(amino acids) was proposed to prepare antibody formulation in a salt-dissociable precipitated state without protein denaturation. Here, we investigated the stabilization effect of PPC of therapeutic antibodies with poly-l-glutamic acid on agitation and thermal stress as forms of mechanical and non-mechanical stress, respectively. The precipitated state of PPC prevented the inactivation and aggregation induced by agitation. Similar results were obtained using the suspension state of PPC, but the stabilizing effects were slightly inferior to those of the PPC precipitate. PPC precipitate and PPC suspension prevented heat-induced inactivation of the antibodies, but showed little effect on heat-induced aggregation. Thus, PPC is a new candidate as a simple storage method for antibodies in aqueous solution, as an alternative state for freeze-drying.


Journal of Pharmaceutical Sciences | 2015

Feasibility of Antibody–Poly(Glutamic Acid) Complexes: Preparation of High-Concentration Antibody Formulations and Their Pharmaceutical Properties

Shunsuke Izaki; Takaaki Kurinomaru; Takuya Maruyama; Takayuki Uchida; Kenji Handa; Tomoaki Kimoto; Kentaro Shiraki

Development of high-concentration antibody formulations for subcutaneous administration remains challenging. Recently, a precipitation-redissolution method was proposed to prepare suspensions or precipitates of salt-dissociable protein-poly(amino acid) complexes. To elucidate the utility of this method for protein therapy, we investigated the feasibility of a precipitation-redissolution method using poly(amino acid) for high-concentration antibody formulation. Omalizumab and adalimumab formulations of 150 mg/mL could be prepared using poly-l-glutamic acid (polyE) from low-concentration stock solutions. Enzyme-linked immunosorbent assay, circular dichroism, and size-exclusion chromatography revealed that the formation of antibody-polyE complex and precipitation-redissolution process did not significantly affect the immunoreactivity or secondary structure of the antibodies. The precipitation-redissolution method was less time-consuming and more effective than lyophilization-redissolution, evaporation-redissolution, and ultrafiltration from the viewpoint of final yield. Scalability was confirmed from 400 μL to 1.0 L. The general toxicity and pharmacokinetic profiles of the antibody-polyE complex formulations were similar to those of conventional antibody formulations. These results suggested that the precipitation-redissolution method using poly(amino acid) has great potential as a concentration method for antibody formulation and medicinal use.


Journal of Bioscience and Bioengineering | 2015

Protein-poly(amino acid) precipitation stabilizes a therapeutic protein l-asparaginase against physicochemical stress.

Takuya Maruyama; Shunsuke Izaki; Takaaki Kurinomaru; Kenji Handa; Tomoaki Kimoto; Kentaro Shiraki

Long-term storage in aqueous solution has been demanded for the practical application of therapeutic proteins. Recently, a precipitation-redissolution method was proposed to prepare salt-dissociable protein-polyelectrolyte complex (PPC). To elucidate the utility of the complex for storage of proteins, we investigated the stress tolerance of PPC precipitates containing l-asparaginase (ASNase) and poly-l-lysine (polyK). PPC precipitate containing ASNase and polyK was prepared by precipitation-redissolution method. The sample was treated to three types of stress, i.e., heat, shaking, and oxidation. The protein concentration, enzyme activity, and CD spectrum of the supernatants of samples were measured after stressed. PPC precipitate consisting of ASNase and polyK showed tolerance against thermal and shaking stress compared to the native solution. In addition, PPC precipitate protected ASNase from inactivation by oxidation. PPC precipitate of ASNase/polyK complex successfully stabilized ASNase against physicochemical stresses. These results suggest that the PPC precipitate has great potential as a storage method in aqueous solution for unstable proteins.


Archive | 1984

Pharmaceutical composition containing urokinase

Fujio Nakagame; Haruo Honda; Teppei Maruyama; Noriko Saito; Tomoaki Kimoto


Aaps Pharmscitech | 2015

Design and Evaluation of the Highly Concentrated Human IgG Formulation Using Cyclodextrin Polypseudorotaxane Hydrogels

Taishi Higashi; Anna Tajima; Naoko Ohshita; Tatsunori Hirotsu; Irhan Ibrahim Abu Hashim; Keiichi Motoyama; Sawako Koyama; Ruriko Iibuchi; Shiuhei Mieda; Kenji Handa; Tomoaki Kimoto; Hidetoshi Arima


Archive | 2016

Protein aqueous suspension

Shunsuke Izaki; Tomoaki Kimoto; Kenji Handa; Shiuhei Mieda; Kentaro Shiraki; Takaaki Kurinomaru; Takuya Maruyama


Archive | 2016

PROTEIN AQUEOUS SUSPENSION PREPARATION

Shunsuke Izaki; Tomoaki Kimoto; Kenji Handa; Shiuhei Mieda; Kentaro Shiraki; Takaaki Kurinomaru; Takuya Maruyama


Asian Journal of Pharmaceutical Sciences | 2016

Improvement of physicochemical stability of highly-concentrated antibodies using cyclodextrin polypseudorotaxane hydrogels

Naoko Ohshita; Anna Tajima; Taishi Higashi; Keiichi Motoyama; Sawako Koyama; Ruriko Iibuchi; Shiuhei Mieda; Kenji Handa; Tomoaki Kimoto; Hidetoshi Arima

Collaboration


Dive into the Tomoaki Kimoto's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge